Infectious Diseases

Overview

The groups of this area aim to improve the outcomes of patients with infectious diseases. The Epidemiology and Public Health group focuses on the epidemiology and prevention of healthcare acquired infections, transmissible infections and on the new vaccines. The Infectious Diseases group focuses on improving the strategies of clinical problems observed in clinical practice. The Microbiology group studies the mechanisms of antimicrobial resistance, pathogenicity, genomic epidemiology and infectious diseases diagnostics. The CRIPS group focuses on developing translational and clinical research in critical care, while the SODIR group works in the areas of sepsis, organ dysfunction and resuscitation. There is also a group focused on clinical research on children’s infectious diseases and primary immunodeficiencies. Finally, the CIBBIM-Nanomedicine group Works in the synthesis, characterization and applications of engineered inorganic nanoparticles in the field of infectious diseases.

Publications

260

total

1322

impact factor

5.08

average impact factor

Group Leader: Jordi Rello

team

group-zoom

zoom

group-download

download

We expanded research in SARI, particularly in influenza and other respiratory viruses. We developed an assessment of the degree of evidence of clinical practice guidelines in different respiratory infections. Proposals of recommendations on controversial issues using MDCA methodology has been developed. In lung transplant, we analyze cytokines in donors and reported a multicenter collaboration assessing ICU admissions by Acute Respiratory Failure. We participated in different research networks such as the IRI-ID and the SMART study, assessing pk/pD of antimicrobials. A new definition of respiratory infections in ventilated children has been incorporated for surveillance to VINCAT. Results of the multicenter international study on VAE was reported and a new multicenter study of VAE in pediatric ICUs was launched. Lastly, we are leading the research projects of WP5 in CIBERES regarding evidence-based medicine and guidelines in pneumonia. Several topics have been registered in PROSPERO.

38

total

204

impact factor

5^.38

average impact factor

SELECTED ARTICLES

Mazo C, Pont T, Ballesteros MA, López E, Rellán L, Robles JC, Rello J.
Pneumonia versus graft dysfunction as the cause of acute respiratory failure after lung transplant: a 4-year multicentre prospective study in 153 adults requiring intensive care admission.
Eur Respir J. 2019 Oct 1;54(3).
DOI: 10.1183/13993003.01512-2018.
IF: 11.807
Rello J, Alp E, Vandana KE.
Infectious diseases: the 10 common truths I never believed.
Intensive Care Med. 2019 Feb;45(2):243-245.
DOI: 10.1007/s00134-018-5272-z.
IF: 18.967
Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, Roberts JA, Schouten J, Giamarellou H, Rello J, De Waele J, Shorr AF, Leone M, Poulakou G, Depuydt P, Garnacho-Montero J.
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
Intensive Care Med. 2020 Feb ;46(2):245-265.
DOI: 10.1007/s00134-019-05866-w.
IF: 18.967
Welte T, Ingels C, Rello J.
Ten tips for the intensive care management of transplanted lung patients.
Intensive Care Med. 2019 Mar ;45(3):371-373.
DOI: 10.1007/s00134-019-05578-1.
IF: 18.967
Blot S, Antonelli M, Arvaniti K, Blot K, Creagh-Brown B, de Lange D, De Waele J, Deschepper M, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovestky F, Maseda E, Montravers P, Mikstacki A, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D; Abdominal Sepsis Study (AbSeS) group on behalf of the Trials Group of the European Society of Intensive Care Medicine.
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project.
Intensive Care Med. 2019 Dec;45(12):1703-1717. doi: 10.1007/s00134-019-05819-3.
IF: 18.967

View all publications